Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorIndiana University

About this trial

The main purpose of this study is to determine which type of medication, sufentanil or methadone, is better at controlling pain during and, more importantly, after surgery in patients undergoing a head and neck dissection with free flap or rotational tissue reconstruction. Prior to their operation, subjects will be randomized to receive either Sufentanil or Methadone. After surgery, research staff will obtain information about recovery and pain levels.

Eligibility criteria

Qualifiers

• Patients undergoing head and neck dissection with free flap or rotational reconstruction at Indiana University Health Adult Academic Health Center

ASA class 1, 2, or 3 (See Appendix)

Age 18 to 80

male or female

Disqualifiers

Any contraindication to opiates, (i.e. allergy to opioids, substance use disorder) as determined by PI review and any contraindications reported by the patient

Patient on home methadone at any dose

Any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery

Known true allergy to the study medications (sufentanil, methadone)

Trial design

Treatments tested in this trial

  • sufentanil
  • methadone

Treatment groups

128 Participants
are divided into 2 treatment groups

Sponsors and collaborators